| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Phio Pharmaceuticals Corp. (PHIO) has 7 insiders with recent SEC Form 4 filings, including 12 buys and 4 sells. PHIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 411.4K | $534.8K | - | |
| CFO | 94.0K | $122.2K | - | |
| Dir | 45.7K | $59.3K | - | |
| Dir | 38.7K | $50.3K | - | |
| Dir | 37.8K | $49.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2022 | Bitterman Robert J | Interim Executive Chairman | Buy | 1 | $1,750.00 | $1,750.00 | New | |
| Aug 16, 2021 | Dispersyn Gerrit | President &CEO | Buy | 6,000 | $1.63 | $9,780.00 | +6.7% | |
| Mar 4, 2021 | Dispersyn Gerrit | President &CEO | Buy | 1,953 | $2.56 | $4,999.68 | +2.2% | |
| Mar 3, 2021 | Ferrara Robert L | Director | Buy | 682 | $3.15 | $2,148.30 | +5.5% | |
| Mar 3, 2021 | Dispersyn Gerrit | President &CEO | Buy | 2,500 | $3.03 | $7,575.00 | +2.9% | |
| Aug 19, 2020 | Dispersyn Gerrit | President &CEO | Buy | 2,000 | $2.50 | $5,000.00 | +13.9% | |
| Oct 2, 2017 | Cauwenbergh Geert | President &CEO | Buy | 10,000 | $0.45 | $4,475.00 | +2.5% | |
| Sep 7, 2017 | Eliseev Alexey | Chief Business Officer | Sell | 176,800 | $0.54 | $94,911.09 | -5.5% | |
| Sep 1, 2017 | Eliseev Alexey | Chief Business Officer | Sell | 23,200 | $0.57 | $13,182.24 | -2.0% | |
| Aug 24, 2017 | Cauwenbergh Geert | President &CEO | Buy | 10,000 | $0.55 | $5,482.89 | +2.6% |